Propanc Biopharma, Inc. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2011 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Propanc Biopharma, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2011 to 2025.
  • Propanc Biopharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending June 30, 2025 was -$4.22M, a 884% decline year-over-year.
  • Propanc Biopharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending June 30, 2025 was -$58.9M, a 2788% decline year-over-year.
  • Propanc Biopharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2025 was -$58.9M, a 2788% decline from 2024.
  • Propanc Biopharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2024 was -$2.04M, a 33.5% increase from 2023.
  • Propanc Biopharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -$3.07M, a 4.44% increase from 2022.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$58.9M -$56.8M -2788% Jul 1, 2024 Jun 30, 2025 10-K 2025-09-29
2024 -$2.04M +$1.03M +33.5% Jul 1, 2023 Jun 30, 2024 10-K 2025-09-29
2023 -$3.07M +$143K +4.44% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 -$3.21M -$609K -23.4% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-28
2021 -$2.6M +$1.94M +42.7% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-28
2020 -$4.54M +$509K +10.1% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 -$5.05M +$1.49M +22.8% Jul 1, 2018 Jun 30, 2019 10-K 2020-10-01
2018 -$6.54M +$1.6M +19.7% Jul 1, 2017 Jun 30, 2018 10-K 2019-10-15
2017 -$8.14M +$1.24M +13.2% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-17
2016 -$9.38M -$6.37M -212% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-28
2015 -$3.01M -$2.12M -239% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-28
2014 -$888K +$440K +33.2% Jul 1, 2013 Jun 30, 2014 10-K 2015-09-30
2013 -$1.33M +$10.3M +88.6% Jul 1, 2012 Jun 30, 2013 10-K 2014-10-14
2012 -$11.7M -$9.5M -438% Jul 1, 2011 Jun 30, 2012 10-K 2013-10-15
2011 -$2.17M Jul 1, 2010 Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.